Amoy Diagnostics Co (SZSE:300685) GF Value : ¥35.01 (As of Dec. 11, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co GF Value?

As of today (2024-12-11), Amoy Diagnostics Co's share price is ¥24.90. Amoy Diagnostics Co's GF Value is ¥35.01. Therefore, Amoy Diagnostics Co's Price-to-GF-Value for today is 0.71. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Amoy Diagnostics Co is Modestly Undervalued.

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

Amoy Diagnostics Co (SZSE:300685) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Amoy Diagnostics Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	24.90	/	35.01
	=	0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amoy Diagnostics Co GF Value Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co Headlines

No Headlines